Waystar vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Waystar is a healthcare payments and revenue cycle technology platform processing over $5 trillion in claims annually for hospitals, health systems, and physician groups.
About
Waystar is a healthcare technology company formed through the 2019 merger of ZirMed and Navicure that provides cloud-based revenue cycle management technology to healthcare providers. The platform automates the complex workflows involved in healthcare payments including eligibility verification, claims submission, denial management, payment posting, and patient payment collection. Waystar processes over $5 trillion in annual claims for a network of over 1,000 health plan and payer connections, making it one of the largest healthcare clearinghouse and RCM technology providers in the United States. The company serves hospitals, health systems, physician practices, and ancillary care providers of all sizes through a SaaS platform that integrates with major EHR systems. Waystar went public on Nasdaq in 2024 following years of private equity ownership under EQT Partners. The company uses AI to improve claim accuracy before submission, prioritize denial appeals, and automate patient payment workflows. Waystar's scale and network of payer connections make it a critical piece of healthcare financial infrastructure for providers seeking to improve cash flow and reduce administrative costs.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.